4//SEC Filing
Grygiel Nancy A. 4
Accession 0001127602-25-013783
CIK 0000318154other
Filed
May 7, 8:00 PM ET
Accepted
May 8, 8:56 PM ET
Size
8.5 KB
Accession
0001127602-25-013783
Insider Transaction Report
Form 4
AMGEN INCAMGN
Grygiel Nancy A.
SVP & CCO
Transactions
- Award
Common Stock
2025-05-06+591→ 8,463 total - Award
Nqso (Right to Buy)
2025-05-06$270.44/sh+3,824$1,034,163→ 3,824 totalExercise: $270.44From: 2026-05-06Exp: 2035-05-06→ Common Stock (3,824 underlying)
Holdings
- 102.927(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 67 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F3]These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
- [F4]These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001816414
Filing Metadata
- Form type
- 4
- Filed
- May 7, 8:00 PM ET
- Accepted
- May 8, 8:56 PM ET
- Size
- 8.5 KB